Regulatory news and experts insights.

Glabridine is an isoflavonoid (isoflavane) extracted from Glycyrrhiza glabra (licorice root). It is widely used in cosmetics for its skin-lightening and anti-tyrosinase activity, as well as for its antioxidant and anti-inflammatory properties. It is mainly found in skincare products, anti-aging creams, and sunscreens.

HOMONOPAL, également connu sous le nom de Pinoacétaldéhyde, est un aldéhyde aromatique synthétique couramment utilisé dans les compositions parfumées. Son numéro CAS est 33885-51-7. Reconnu pour son odeur verte, florale et légèrement aldéhydée, ce composé apporte de la fraîcheur et de la vivacité aux accords parfumés, en particulier dans les parfums de luxe, les produits de soin personnel et les formulations de nettoyage.

The European Chemicals Agency (ECHA) has proposed new restrictions on hexavalent chromium (Cr(VI)) under REACH to protect workers and the environment. Key industrial uses may continue only if exposure and emission limits are met, while a public consultation starting June 18, 2025 allows companies to provide technical and socio-economic data.

The PPWR sets new standards for sustainable packaging in Europe, focusing on recyclability, mandatory recycled content, waste reduction, and harmonized labeling. CEHTRA helps businesses stay compliant and adopt circular, eco-friendly packaging solutions.

Annex VIII to the CLP Regulation harmonises the poison centre notification (PCN) process across the EU. Importers and downstream users placing hazardous mixtures on the market must submit detailed information via the ECHA portal and include a Unique Formula Identifier (UFI). CEHTRA assists companies in reviewing portfolios, preparing and submitting PCN notifications, and ensuring full compliance with EU requirements.

ECHA developed in 2022 a recommended (i.e. not mandatory) framework guidance to applicants for approval of biocidal active substances but also to Member State Competent Authorities (MSCAs) on how to perform an analysis of alternatives (AoA) to active substances being candidate for substitution (CfS) according to Art. 10(1) of the Biocidal Products Regulation ((EU) 528/2012). The guidance has been adopted at BPC-45 meeting and published in January 2023.

On 2nd of December 2021, the ECHA Biocidal Products Committee (BPC) recommended the approval of ABDAC/BKC and adopted the BPC opinion for PT2 by simple majority. Two Member States (Germany and Finland) raised their concerns about unacceptable risk for environment, mainly for the soil compartment.

In the recent meeting of Coordination Group (CG-54), a proposal of the Austrian Member State was discussed which has been raised in a CG e-consultation, concerning information on the use frequency of products (“Number and timing of application”) for use in PT 1, PT2 and PT4 given by the applicants in SPC and PAR for BPR product authorization.